Genfleet (HKG: 02595)

Shanghai, China · Founded 2017 · Publicly Held

GenFleet Therapeutics (Shanghai) Inc is a biopharmaceutical company focused on developing novel treatment options in the fields of oncology, covering different lines of treatments of multiple solid… Genfleet (HKG: 02595) is based in Shanghai, China and was founded in 2017. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $800 million (Sep 2025). It has raised $205 million.

Last price · $/share

—

Implied valuation

$799.7M

Total raised

$204.8M

Last round

—

How much has Genfleet (HKG: 02595) raised?

$204.8Macross 0 recorded rounds

Free account

More of Genfleet (HKG: 02595) with a free account

·Watch Genfleet (HKG: 02595): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Genfleet (HKG: 02595) investors

10 investors are on record for Genfleet (HKG: 02595), including OrbiMed, Suzhou Guofa Venture Capital, CITIC Capital and Lake Bleu Capital. By type, the record holds 2 hedge funds, 2 asset managers and 1 growth equity firm.

For fundraisers

Raising for a company like Genfleet (HKG: 02595)?

10 investors have backed Genfleet (HKG: 02595).

See all 10 investors →

Frequently asked about Genfleet (HKG: 02595)

How much has Genfleet (HKG: 02595) raised?: Genfleet (HKG: 02595) has raised $204.8M in total across 0 recorded funding rounds.